CompuGroup Medical SE promoted to MDAX
Shares will be listed in the MDAX from September 23, continued listing in the TecDAX
Koblenz, September 05, 2019 - CompuGroup Medical SE shares will in future be listed in the MDAX, as Deutsche Börse announced. The change in the index composition will take effect on September 23. The company meets the two required quantitative admission criteria of market capitalization and trading volume. Michael Rauch, CFO of CompuGroup Medical SE: "We are pleased about the admission to the MDAX and the continued listing in the TecDAX and assume that our shares will become even more relevant for investors, especially in the technology and healthcare sectors."
"We consider the ascent to the MDAX, while at the same time remaining in the TecDax, to be an appreciation of our performance as a 'digitizer' in the healthcare industry. This helps us strengthening our efforts making healthcare systems better and more efficient worldwide", says Frank Gotthardt, Founder and CEO of CompuGroup Medical SE.
CompuGroup Medical SE shares have been listed in the SDAX since September 2018.
About CompuGroup Medical SE CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of approximately EUR 717 million in 2018, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million health professionals as users, including doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 5,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.
Contact for media representatives:
CompuGroup Medical SE Michael Franz Head of Brand Communication P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 e-Mail: email@example.com
Contact for investors and analysts: CompuGroup Medical SE Claudia Thomé Head of Investor Relations T +49 (0) 261 8000-7030 F +49 (0) 261 8000-3200 E-Mail: firstname.lastname@example.org
05.09.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz
Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: email@example.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: SDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 869003 End of News DGAP News Service